166 related articles for article (PubMed ID: 36959433)
1. Protective Effects and Potential Mechanism of Tongxinluo on Mice with Thromboangiitis Obliterans Induced by Sodium Laurate.
Gu JJ; Wei YR; Ma K; Wang XQ; Gao HL
Chin J Integr Med; 2023 Jul; 29(7):608-616. PubMed ID: 36959433
[TBL] [Abstract][Full Text] [Related]
2. Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats.
Zhang Z; Ji J; Zhang D; Ma M; Sun L
Phytomedicine; 2020 Jan; 66():153110. PubMed ID: 31790900
[TBL] [Abstract][Full Text] [Related]
3. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats.
Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X
J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Shenfu injection on thromboangiitis obliterans model rats.
Hong F; He C; Liu X; Tu G; Guo F; Yang S
J Ethnopharmacol; 2011 Nov; 138(2):458-62. PubMed ID: 21982791
[TBL] [Abstract][Full Text] [Related]
5. MiR-223 alleviates thrombus and inflammation in thromboangiitis obliterans rats by regulating NLRP3.
Zhou H; Li CL; Xia PZ; He YX
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10605-10611. PubMed ID: 33155218
[TBL] [Abstract][Full Text] [Related]
6. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1/RAGE/ NF-κB pathway.
Liu C; Kong X; Wu X; Wang X; Guan H; Wang H; Wang L; Jin X; Yuan H
Biochem Biophys Res Commun; 2018 Oct; 505(1):282-289. PubMed ID: 30245136
[TBL] [Abstract][Full Text] [Related]
8. Effects of tongxinluo on the neointima formation and expression of inflammatory cytokines in rats after carotid artery balloon injury.
Yao EH; Wang HJ; Xu CS
Indian J Pharmacol; 2014; 46(5):510-4. PubMed ID: 25298580
[TBL] [Abstract][Full Text] [Related]
9. Effect of bradykinin on rats with thromboangiitis obliterans through PI3K/Akt signaling pathway.
Du YM; Du BH; Yang J; Zang S; Wang XP; Mao X; Zhang W; Jiang LP
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10169-10176. PubMed ID: 31799689
[TBL] [Abstract][Full Text] [Related]
10. Tongxinluo reduces brain edema and inhibits post-ischemic inflammation after middle cerebral artery occlusion in rats.
Cai M; Yu Z; Wang L; Song X; Zhang J; Zhang Z; Zhang W; Li W; Xiang J; Cai D
J Ethnopharmacol; 2016 Apr; 181():136-45. PubMed ID: 26805468
[TBL] [Abstract][Full Text] [Related]
11. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.
Zou C; Liu L; Huang C; Hu S
Front Pharmacol; 2022; 13():1018438. PubMed ID: 36304158
[TBL] [Abstract][Full Text] [Related]
12. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip.
Ma J; Qiao L; Meng L; Ma L; Zhao Y; Liu X; Ni M; Zhang Y
Biomed Pharmacother; 2019 May; 113():108767. PubMed ID: 30870720
[TBL] [Abstract][Full Text] [Related]
13. Tongxinluo Activates PI3K/AKT Signaling Pathway to Inhibit Endothelial Mesenchymal Transition and Attenuate Myocardial Fibrosis after Ischemia-Reperfusion in Mice.
Wei YR; Hou YL; Yin YJ; Li Z; Liu Y; Han NX; Wang ZX; Liu L; Wang XQ; Hao YJ; Ma K; Gu JJ; Jia ZH
Chin J Integr Med; 2024 Feb; ():. PubMed ID: 38386252
[TBL] [Abstract][Full Text] [Related]
14. Integration of traditional Chinese medicine and nibble debridement and dressing method reduces thrombosis and inflammatory response in the treatment of thromboangiitis obliterans.
Li J; Zhong J; Huang C; Guo J; Wang B
Ann Transl Med; 2021 Sep; 9(18):1413. PubMed ID: 34733965
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect and acting mechanism of Tongxinluo on IL-1beta-mediated coronary intimal hyperplasia and 5-hydroxytryptamine-induced coronary vasospasm in small swine].
Guan QG; Zeng DY; Sun XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jul; 28(7):627-31. PubMed ID: 18822914
[TBL] [Abstract][Full Text] [Related]
16. Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans.
Wang XB; Wang ML; Chu YJ; Zhou PP; Zhang XY; Zou J; Zuo LH; Shi YY; Kang J; Li B; Cheng WB; Sun Z; Zhang XJ; Du SZ
Phytomedicine; 2023 Apr; 112():154709. PubMed ID: 36774843
[TBL] [Abstract][Full Text] [Related]
17. Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients.
Dellalibera-Joviliano R; Joviliano EE; Silva JS; Evora PR
Clin Exp Immunol; 2012 Oct; 170(1):28-35. PubMed ID: 22943198
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans.
Zou J; Xu W; Li Z; Gao P; Zhang F; Cui Y; Hu J
Ann Med; 2023 Dec; 55(1):2218105. PubMed ID: 37318081
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Jingfang Granules on carrageenan-induced tail thrombosis in mice based on ERK/p38 MAPK signaling pathway].
Zhou JD; Li HH; Li XZ; Li SR; Yang TY; Yao JC; Zhang GM
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2195-2199. PubMed ID: 35531736
[TBL] [Abstract][Full Text] [Related]
20. Study on the antithrombotic effect and physiological mechanism of okanin.
Liu Y; Xiong B; Qiu X; Hao H; Sha A
Biomed Pharmacother; 2022 Sep; 153():113358. PubMed ID: 35785699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
